CDT Equity Announces Patent Filing From Sarborg Limited For Its Intellectual Property Covering Novel Solid Forms Of Respiratory Medicine

CDT Equity Inc. (NASDAQ: CDT) has acknowledged a patent filing from Sarborg Limited for novel solid forms of a first-in-class respiratory medicine, targeting a market worth over $20 billion annually. CDT owns 1,290 shares in Sarborg, equating to a 22.7% stake, with Sarborg's recent capital raise valuing CDT's investment at approximately $161 million, based on a share price of $125,000.